|Positive WB detected in||A549 cells, HL-60 cells, Y79 cells, U-937 cells, rat spleen tissue, U-87 MG cells, HEK-293T cells|
|Positive IP detected in||mouse spleen tissue|
|Positive IF detected in||U-251 cells|
|Positive FC detected in||THP-1 cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
The immunogen of 20415-1-AP is MIF Fusion Protein expressed in E. coli.
|Tested Reactivity||human, rat, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||MIF fusion protein Ag14058|
|Full Name||macrophage migration inhibitory factor (glycosylation-inhibiting factor)|
|Calculated molecular weight||115 aa, 12 kDa|
|Observed molecular weight||12 kDa|
|GenBank accession number||BC000447|
|Gene ID (NCBI)||4282|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
|Product Specific Protocols|
|WB protocol for MIF antibody 20415-1-AP||Download protocol|
|IF protocol for MIF antibody 20415-1-AP||Download protocol|
|IP protocol for MIF antibody 20415-1-AP||Download protocol|
|FC protocol for MIF antibody 20415-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.
Proteomic analysis of human periodontal ligament cells under hypoxia.
A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement.
Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection.
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
Ryan (Verified Customer) (02-27-2019)
Tissue was fixed in PFA with no additional antigen retrieval. Co-localisation with microglia based on known markers (not shown).